ONCOGENOMX

OncoGenomX provides the first cancer profiling technology reflective of biology, clinical behavior, and pharmacological vulnerabilities of individual cancers to guide decisions on the composition of therapy regimen, combining the most effective drugs with the highest chance of conveying maximum clinical and health economic benefit... Our Chief Technology Officer and Chief Diagnostics Officer will join after successful series A investment.

Also known as: OncoGenomX AG, OncoGenomX Inc.

Registration numbers: CH-280.3.023.929-8 (W)

VAT numbers: CHE-268.986.161

Primary location: Basel Switzerland